2023
MUS81 cleaves TOP1‑derived lesions and other DNA-protein cross‑links
MARINI PALOMEQUE, María Victoria, Fedor NIKULENKOV, Pounami SAMADDER, Sissel JUUL, Birgitta R. KNUDSEN et. al.Základní údaje
Originální název
MUS81 cleaves TOP1‑derived lesions and other DNA-protein cross‑links
Autoři
MARINI PALOMEQUE, María Victoria (380 Itálie, domácí), Fedor NIKULENKOV (203 Česká republika, domácí), Pounami SAMADDER (356 Indie, domácí), Sissel JUUL, Birgitta R. KNUDSEN a Lumír KREJČÍ (203 Česká republika, garant, domácí)
Vydání
BMC Biology, London, BMC, 2023, 1741-7007
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.400 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130789
Organizační jednotka
Lékařská fakulta
UT WoS
000990321800001
Klíčová slova anglicky
DNA-protein cross-links repair; MUS81; TDP1; Topoisomerase 1
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 2. 2024 15:03, Mgr. Tereza Miškechová
Anotace
V originále
Background DNA-protein cross-links (DPCs) are one of the most deleterious DNA lesions, originating from various sources, including enzymatic activity. For instance, topoisomerases, which play a fundamental role in DNA metabolic processes such as replication and transcription, can be trapped and remain covalently bound to DNA in the presence of poisons or nearby DNA damage. Given the complexity of individual DPCs, numerous repair pathways have been described. The protein tyrosyl-DNA phosphodiesterase 1 (Tdp1) has been demonstrated to be responsible for removing topoisomerase 1 (Top1). Nevertheless, studies in budding yeast have indicated that alternative pathways involving Mus81, a structure-specific DNA endonuclease, could also remove Top1 and other DPCs. Results This study shows that MUS81 can efficiently cleave various DNA substrates modified by fluorescein, streptavidin or proteolytically processed topoisomerase. Furthermore, the inability of MUS81 to cleave substrates bearing native TOP1 suggests that TOP1 must be either dislodged or partially degraded prior to MUS81 cleavage. We demonstrated that MUS81 could cleave a model DPC in nuclear extracts and that depletion of TDP1 in MUS81-KO cells induces sensitivity to the TOP1 poison camptothecin (CPT) and affects cell proliferation. This sensitivity is only partially suppressed by TOP1 depletion, indicating that other DPCs might require the MUS81 activity for cell proliferation. Conclusions Our data indicate that MUS81 and TDP1 play independent roles in the repair of CPT-induced lesions, thus representing new therapeutic targets for cancer cell sensitisation in combination with TOP1 inhibitors.
Návaznosti
EF16_025/0007381, projekt VaV |
| ||
GX21-22593X, projekt VaV |
| ||
206292/E/17/Z, interní kód MU |
|